US Stock MarketDetailed Quotes

DARE Dare Bioscience

Watchlist

4.2000
+0.7000+20.00%

Close Aug 13 16:00 ET

35.89MMarket Cap-3620P/E (TTM)

Dare Bioscience Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

295.93%12.9M

57.73%-6.81M

-114.81%-38.86M

-38.70%-8.18M

-192.72%-7.97M

22.04%-6.59M

-30.58%-16.12M

37.11%-18.09M

40.53%-5.9M

551.37%8.6M

Net income from continuing operations

247.34%12.91M

16.00%-6.76M

2.54%-30.16M

68.28%-5.06M

-18.22%-8.3M

-2,216.49%-8.76M

4.24%-8.04M

20.02%-30.95M

-67.08%-15.94M

44.58%-7.02M

Operating gains losses

--209.68K

--600K

----

Depreciation and amortization

60.55%15.44K

13.36%10.78K

58.51%38.36K

-6.04%9.98K

205.21%9.26K

80.77%9.62K

81.90%9.51K

-8.37%24.2K

50.73%10.62K

-52.17%3.03K

Other non cash items

---31.81K

125.34%202.67K

439.59%78.32K

-1,733.84%-108.29K

----

1,021.71%89.94K

55.52%-23.06K

77.95%-5.91K

-234.14%-27.1K

Change In working capital

-153.50%-762K

82.97%-1.5M

-206.01%-11.34M

-138.31%-3.64M

-102.15%-324.91K

115.11%1.42M

-96.73%-8.8M

22.59%10.7M

1,380.43%9.51M

11.58%15.09M

-Change in receivables

-73.52%483.5K

37.25%-436.46K

235.15%753.95K

-69.34%180.55K

-105.66%-557.29K

117.55%1.83M

-18.99%-695.55K

18.58%-557.84K

159.54%588.88K

251.73%9.85M

-Change in prepaid assets

259.83%1.58M

509.46%1.71M

85.55%-605.26K

383.65%1.06M

73.57%-259.35K

-214.44%-991.11K

90.30%-416.46K

-573.17%-4.19M

455.54%219.51K

-87.21%-981.13K

-Change in payables and accrued expense

-180.40%-2.06M

88.66%-538.3K

-190.00%-6.91M

-171.69%-3.81M

-706.77%-921.85K

134.16%2.56M

-520.24%-4.75M

641.66%7.68M

519.53%5.31M

633.70%151.93K

-Change in other current assets

343.44%243.16K

43.70%-207.14K

-382.19%-10.3K

1,238.58%845.84K

-796.76%-543.05K

--54.84K

---367.93K

-82.51%3.65K

-104.24%-74.29K

-34.22%77.94K

-Change in other current liabilities

-19.86%-117.15K

-26.04%-120.8K

----

---97.74K

---95.85K

----

-Change in other working capital

53.39%-898.21K

23.25%-1.9M

-158.84%-4.57M

-155.53%-1.93M

-70.58%1.76M

-97.41%-1.93M

-242.28%-2.48M

-13.56%7.76M

665.04%3.47M

-46.28%5.99M

Cash from discontinued investing activities

Operating cash flow

295.93%12.9M

57.73%-6.81M

-114.81%-38.86M

-38.70%-8.18M

-192.72%-7.97M

22.04%-6.59M

-30.58%-16.12M

37.11%-18.09M

40.53%-5.9M

551.37%8.6M

Investing cash flow

Cash flow from continuing investing activities

-285.23K

-7.3K

-898.00%-629.43K

-22,418.76%-607.33K

59.82%-22.1K

-334.24%-63.07K

-2.7K

-278.70%-55K

Net PPE purchase and sale

---285.23K

---7.3K

-898.00%-629.43K

-22,418.76%-607.33K

59.82%-22.1K

--0

-334.24%-63.07K

---2.7K

-278.70%-55K

Cash from discontinued investing activities

Investing cash flow

---285.23K

---7.3K

-898.00%-629.43K

-22,418.76%-607.33K

59.82%-22.1K

--0

-334.24%-63.07K

---2.7K

-278.70%-55K

Financing cash flow

Cash flow from continuing financing activities

-74.49%115.37K

-98.92%14.03K

1,064.04%15.64M

530,926,900.00%5.31M

192,365.93%8.58M

-66.23%452.2K

1.3M

-98.23%1.34M

-100.00%-1

-99.99%4.46K

Net issuance payments of debt

---66.8K

---200.39K

--267.19K

---200.39K

--467.58K

--0

----

Net common stock issuance

-59.54%182.98K

--215.11K

666.91%9.35M

--785.76K

--8.11M

--452.2K

--0

-98.38%1.22M

--0

Proceeds from stock option exercised by employees

--0

942.80%1.3M

200.00%1

--0

--1.3M

-76.61%124.6K

-100.00%-1

-97.82%4.46K

Net other financing activities

---815

---690

--4.72M

----

Cash from discontinued financing activities

Financing cash flow

-74.49%115.37K

-98.92%14.03K

1,064.04%15.64M

530,926,900.00%5.31M

192,365.93%8.58M

-66.23%452.2K

--1.3M

-98.23%1.34M

-100.00%-1

-99.99%4.46K

Net cash flow

Beginning cash position

-80.00%3.97M

-68.82%10.81M

-32.91%34.67M

-64.77%14.23M

-57.39%13.66M

-49.57%19.83M

-32.91%34.67M

1,006.64%51.67M

-11.37%40.39M

251.97%32.07M

Current changes in cash

307.61%12.73M

54.07%-6.81M

-41.89%-23.85M

41.06%-3.48M

-93.21%580.35K

13.73%-6.13M

-20.00%-14.82M

-135.71%-16.81M

-196.90%-5.9M

-76.59%8.55M

Effect of exchange rate changes

146.75%14.56K

-78.26%-39.23K

95.12%-9.59K

-67.34%58.6K

93.49%-15.03K

77.07%-31.15K

-140.49%-22.01K

-208.78%-196.34K

1,063.84%179.43K

-264.64%-230.75K

End cash Position

22.33%16.71M

-80.00%3.97M

-68.82%10.81M

-64.77%14.23M

-57.39%13.66M

-49.57%19.83M

-32.91%34.67M

-11.37%40.39M

Free cash flow

291.60%12.62M

57.68%-6.82M

-117.54%-39.49M

-48.94%-8.79M

-193.57%-8M

22.05%-6.59M

-30.53%-16.12M

36.93%-18.15M

40.51%-5.9M

554.40%8.55M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	295.93%12.9M	57.73%-6.81M	-114.81%-38.86M	-38.70%-8.18M	-192.72%-7.97M	22.04%-6.59M	-30.58%-16.12M	37.11%-18.09M	40.53%-5.9M	551.37%8.6M
Net income from continuing operations	247.34%12.91M	16.00%-6.76M	2.54%-30.16M	68.28%-5.06M	-18.22%-8.3M	-2,216.49%-8.76M	4.24%-8.04M	20.02%-30.95M	-67.08%-15.94M	44.58%-7.02M
Operating gains losses	--209.68K	--600K	----	----	----	----	----	----	----	----
Depreciation and amortization	60.55%15.44K	13.36%10.78K	58.51%38.36K	-6.04%9.98K	205.21%9.26K	80.77%9.62K	81.90%9.51K	-8.37%24.2K	50.73%10.62K	-52.17%3.03K
Other non cash items	---31.81K	125.34%202.67K	439.59%78.32K	-1,733.84%-108.29K	----	----	1,021.71%89.94K	55.52%-23.06K	77.95%-5.91K	-234.14%-27.1K
Change In working capital	-153.50%-762K	82.97%-1.5M	-206.01%-11.34M	-138.31%-3.64M	-102.15%-324.91K	115.11%1.42M	-96.73%-8.8M	22.59%10.7M	1,380.43%9.51M	11.58%15.09M
-Change in receivables	-73.52%483.5K	37.25%-436.46K	235.15%753.95K	-69.34%180.55K	-105.66%-557.29K	117.55%1.83M	-18.99%-695.55K	18.58%-557.84K	159.54%588.88K	251.73%9.85M
-Change in prepaid assets	259.83%1.58M	509.46%1.71M	85.55%-605.26K	383.65%1.06M	73.57%-259.35K	-214.44%-991.11K	90.30%-416.46K	-573.17%-4.19M	455.54%219.51K	-87.21%-981.13K
-Change in payables and accrued expense	-180.40%-2.06M	88.66%-538.3K	-190.00%-6.91M	-171.69%-3.81M	-706.77%-921.85K	134.16%2.56M	-520.24%-4.75M	641.66%7.68M	519.53%5.31M	633.70%151.93K
-Change in other current assets	343.44%243.16K	43.70%-207.14K	-382.19%-10.3K	1,238.58%845.84K	-796.76%-543.05K	--54.84K	---367.93K	-82.51%3.65K	-104.24%-74.29K	-34.22%77.94K
-Change in other current liabilities	-19.86%-117.15K	-26.04%-120.8K	----	----	----	---97.74K	---95.85K	----	----	----
-Change in other working capital	53.39%-898.21K	23.25%-1.9M	-158.84%-4.57M	-155.53%-1.93M	-70.58%1.76M	-97.41%-1.93M	-242.28%-2.48M	-13.56%7.76M	665.04%3.47M	-46.28%5.99M
Cash from discontinued investing activities
Operating cash flow	295.93%12.9M	57.73%-6.81M	-114.81%-38.86M	-38.70%-8.18M	-192.72%-7.97M	22.04%-6.59M	-30.58%-16.12M	37.11%-18.09M	40.53%-5.9M	551.37%8.6M
Investing cash flow
Cash flow from continuing investing activities	-285.23K	-7.3K	-898.00%-629.43K	-22,418.76%-607.33K	59.82%-22.1K	0	0	-334.24%-63.07K	-2.7K	-278.70%-55K
Net PPE purchase and sale	---285.23K	---7.3K	-898.00%-629.43K	-22,418.76%-607.33K	59.82%-22.1K	--0	--0	-334.24%-63.07K	---2.7K	-278.70%-55K
Cash from discontinued investing activities
Investing cash flow	---285.23K	---7.3K	-898.00%-629.43K	-22,418.76%-607.33K	59.82%-22.1K	--0	--0	-334.24%-63.07K	---2.7K	-278.70%-55K
Financing cash flow
Cash flow from continuing financing activities	-74.49%115.37K	-98.92%14.03K	1,064.04%15.64M	530,926,900.00%5.31M	192,365.93%8.58M	-66.23%452.2K	1.3M	-98.23%1.34M	-100.00%-1	-99.99%4.46K
Net issuance payments of debt	---66.8K	---200.39K	--267.19K	---200.39K	--467.58K	--0	--0	--0	--0	----
Net common stock issuance	-59.54%182.98K	--215.11K	666.91%9.35M	--785.76K	--8.11M	--452.2K	--0	-98.38%1.22M	--0	--0
Proceeds from stock option exercised by employees	--0	--0	942.80%1.3M	200.00%1	--0	--0	--1.3M	-76.61%124.6K	-100.00%-1	-97.82%4.46K
Net other financing activities	---815	---690	--4.72M	----	----	----	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	-74.49%115.37K	-98.92%14.03K	1,064.04%15.64M	530,926,900.00%5.31M	192,365.93%8.58M	-66.23%452.2K	--1.3M	-98.23%1.34M	-100.00%-1	-99.99%4.46K
Net cash flow
Beginning cash position	-80.00%3.97M	-68.82%10.81M	-32.91%34.67M	-64.77%14.23M	-57.39%13.66M	-49.57%19.83M	-32.91%34.67M	1,006.64%51.67M	-11.37%40.39M	251.97%32.07M
Current changes in cash	307.61%12.73M	54.07%-6.81M	-41.89%-23.85M	41.06%-3.48M	-93.21%580.35K	13.73%-6.13M	-20.00%-14.82M	-135.71%-16.81M	-196.90%-5.9M	-76.59%8.55M
Effect of exchange rate changes	146.75%14.56K	-78.26%-39.23K	95.12%-9.59K	-67.34%58.6K	93.49%-15.03K	77.07%-31.15K	-140.49%-22.01K	-208.78%-196.34K	1,063.84%179.43K	-264.64%-230.75K
End cash Position	22.33%16.71M	-80.00%3.97M	-68.82%10.81M	-68.82%10.81M	-64.77%14.23M	-57.39%13.66M	-49.57%19.83M	-32.91%34.67M	-32.91%34.67M	-11.37%40.39M
Free cash flow	291.60%12.62M	57.68%-6.82M	-117.54%-39.49M	-48.94%-8.79M	-193.57%-8M	22.05%-6.59M	-30.53%-16.12M	36.93%-18.15M	40.51%-5.9M	554.40%8.55M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall